Tyr879

Site Information
AMBIGUOUS SITES: PCDHGA1 (human): , PCDHGA10 (human): , PCDHGA11 (human): , PCDHGA12 (human): , PCDHGA2 (human): , PCDHGA3 (human): , PCDHGA4 (human): , PCDHGA5 (human): , PCDHGA7 (human): , PCDHGA8 (human): , PCDHGA9 (human): , PCDHGB1 (human): , PCDHGB2 (human): , PCDHGB3 (human): , PCDHGB4 (human): , PCDHGB5 (human): , PCDHGB6 (human): , PCDHGB7 (human): , PCDHGC3 (human): , PCDHGC4 (human): , PCDHGC5 (human):
TMGLSARyGPQFTLQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 23129917
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 3 , 4 , 5 )
Disease tissue studied:	non-small cell lung cancer ( 3 ) , non-small cell lung adenocarcinoma ( 3 ) , neuroblastoma ( 1 , 4 , 5 )
Relevant cell line - cell type - tissue:	NCI-H2228 (pulmonary) ( 3 ) , SK-N-BE(2) (neural crest) ( 1 , 4 , 5 )

References
1	Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130 25884760 Curated Info
2	Takahashi T, et al. (2013) New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis. Int J Cancer 133, 2737-43 23716303 Curated Info
3	Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954 Curated Info
4	Guo A (2010) CST Curation Set: 10549; Year: 2010; Biosample/Treatment: cell line, SKNBE(2)/NGF; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info
5	Guo A (2010) CST Curation Set: 10548; Year: 2010; Biosample/Treatment: cell line, SKNBE(2)/NGF; Disease: neuroblastoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991 Curated Info